Chie Masaki

1.7k total citations · 1 hit paper
49 papers, 1.1k citations indexed

About

Chie Masaki is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Chie Masaki has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Surgery and 9 papers in Oncology. Recurrent topics in Chie Masaki's work include Thyroid Cancer Diagnosis and Treatment (43 papers), Thyroid and Parathyroid Surgery (20 papers) and Head and Neck Anomalies (13 papers). Chie Masaki is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (43 papers), Thyroid and Parathyroid Surgery (20 papers) and Head and Neck Anomalies (13 papers). Chie Masaki collaborates with scholars based in Japan, Portugal and Italy. Chie Masaki's co-authors include Kiminori Sugino, Wataru Kitagawa, Koichi Ito, Mitsuji Nagahama, Keiko Ohkuwa, Akifumi Suzuki, Junko Akaishi, Takashi Uruno, Kenichi Matsuzu and Kiyomi Y. Hames and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Medicine and Annals of Surgical Oncology.

In The Last Decade

Chie Masaki

49 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma

2020 248 citations Iwao Sugitani, Yasuhiro Ito et al. Thyroid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chie Masaki Japan	17	1.0k	586	166	142	112	49	1.1k
Keiko Ohkuwa Japan	18	954 0.9×	527 0.9×	196 1.2×	137 1.0×	112 1.0×	46	1.1k
Laura Moss United Kingdom	9	987 1.0×	609 1.0×	133 0.8×	166 1.2×	143 1.3×	16	1.2k
Kazuhisa Toda Japan	17	1.2k 1.1×	631 1.1×	200 1.2×	364 2.6×	114 1.0×	34	1.3k
Kiyomi Y. Hames Japan	14	549 0.5×	266 0.5×	84 0.5×	116 0.8×	74 0.7×	33	722
Uwe Mäder Germany	20	902 0.9×	532 0.9×	174 1.0×	155 1.1×	135 1.2×	38	1.1k
Massimo Salvatori Italy	24	982 1.0×	687 1.2×	54 0.3×	140 1.0×	220 2.0×	65	1.3k
Toshitetsu Hayashi Japan	16	333 0.3×	293 0.5×	61 0.4×	154 1.1×	101 0.9×	55	665
Anthony Glover Australia	17	522 0.5×	409 0.7×	74 0.4×	128 0.9×	66 0.6×	70	970
B Gibelli Italy	14	358 0.4×	251 0.4×	82 0.5×	208 1.5×	72 0.6×	24	724
Emily Reiff United States	14	493 0.5×	495 0.8×	70 0.4×	134 0.9×	104 0.9×	30	995

Countries citing papers authored by Chie Masaki

Since Specialization

Citations

This map shows the geographic impact of Chie Masaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Masaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Masaki more than expected).

Fields of papers citing papers by Chie Masaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Masaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Masaki. The network helps show where Chie Masaki may publish in the future.

Co-authorship network of co-authors of Chie Masaki

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Masaki. A scholar is included among the top collaborators of Chie Masaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Masaki. Chie Masaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saito, Yoshiyuki, Kenichi Matsuzu, Hiroshi Takami, et al.. (2024). Active surveillance vs. surgery in low‐risk papillary thyroid microcarcinoma patients and the risk of loss to follow‐up. Cancer Medicine. 13(16). e70123–e70123. 2 indexed citations

Fujita, Kazuma, Akifumi Suzuki, Mitsuji Nagahama, et al.. (2024). Effects of the Japanese Kampo Medicines Rikkunshito, Shakuyakukanzoto and Goreisan on Lenvatinib Plasma Concentrations in Japanese Patients with Thyroid Cancer. Drugs - Real World Outcomes. 12(1). 153–160. 1 indexed citations

Cirello, Valentina, et al.. (2024). Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives. Panminerva Medica. 66(2). 155–173. 1 indexed citations

Masaki, Chie, Kiminori Sugino, Yoshinori Tanizawa, et al.. (2022). Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study. Drugs - Real World Outcomes. 10(1). 145–158. 3 indexed citations

Yamazaki, Haruhiko, Kiminori Sugino, Jaeduk Yoshimura Noh, et al.. (2022). Clinical course and outcome of differentiated thyroid cancer patients with pregnancy after diagnosis of distant metastasis. Endocrine. 76(1). 78–84. 7 indexed citations

Masaki, Chie, Kiminori Sugino, Junko Akaishi, et al.. (2022). Successful dose escalation of lenvatinib for thyroid cancer after disease progression. Endocrine. 78(1). 77–84. 2 indexed citations

Masaki, Chie, Kiminori Sugino, Naoko Saito, et al.. (2022). Predictors of maximum efficacy of lenvatinib for real-world patients with differentiated thyroid carcinoma. Surgery Today. 52(11). 1660–1669. 2 indexed citations

Sugino, Kiminori, Mitsuji Nagahama, Wataru Kitagawa, et al.. (2021). Cutoff Age Between Pediatric and Adult Thyroid Differentiated Cancer: Is 18 Years Old Appropriate?. Thyroid. 32(2). 145–152. 20 indexed citations

Masaki, Chie, Kiminori Sugino, Sakiko Kobayashi, et al.. (2021). Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients. BMC Cancer. 21(1). 894–894. 14 indexed citations

10.

Sugitani, Iwao, Yasuhiro Ito, Dai Takeuchi, et al.. (2020). Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid. 31(2). 183–192. 248 indexed citations breakdown →

11.

Yamazaki, Haruhiko, Kiminori Sugino, Ryohei Katoh, et al.. (2020). Outcomes for Minimally Invasive Follicular Thyroid Carcinoma in Relation to the Change in Age Stratification in the AJCC 8th Edition. Annals of Surgical Oncology. 28(7). 3576–3583. 15 indexed citations

12.

Yamazaki, Haruhiko, Kiminori Sugino, Kenichi Matsuzu, et al.. (2020). Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma. Endocrine. 70(1). 115–122. 16 indexed citations

13.

Masaki, Chie, Kiminori Sugino, Sakiko Kobayashi, et al.. (2020). Urinalysis by combination of the dipstick test and urine protein–creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer. International Journal of Clinical Oncology. 25(7). 1278–1284. 11 indexed citations

14.

Sugino, Kiminori, Mitsuji Nagahama, Wataru Kitagawa, et al.. (2020). Distant Metastasis in Pediatric and Adolescent Differentiated Thyroid Cancer: Clinical Outcomes and Risk Factor Analyses. The Journal of Clinical Endocrinology & Metabolism. 105(11). e3981–e3988. 35 indexed citations

15.

Masaki, Chie, Kiminori Sugino, Naoko Saito, et al.. (2019). Efficacy and Limitations of Lenvatinib Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer: Real-World Experiences. Thyroid. 30(2). 214–221. 35 indexed citations

16.

Tomoda, Chisato, Kiminori Sugino, Tomoaki Tanaka, et al.. (2017). Globus Symptoms in Patients Undergoing Thyroidectomy: Relationships with Psychogenic Factors, Thyroid Disease, and Surgical Procedure. Thyroid. 28(1). 104–109. 6 indexed citations

17.

Sugino, Kiminori, Mitsuji Nagahama, Wataru Kitagawa, et al.. (2015). Papillary Thyroid Carcinoma in Children and Adolescents: Long‐Term Follow‐Up and Clinical Characteristics. World Journal of Surgery. 39(9). 2259–2265. 38 indexed citations

18.

Sugino, Kiminori, Kaori Kameyama, Mitsuji Nagahama, et al.. (2014). Does Completion Thyroidectomy Improve the Outcome of Patients with Minimally Invasive Follicular Carcinoma of the Thyroid?. Annals of Surgical Oncology. 21(9). 2981–2986. 21 indexed citations

19.

Matsuzu, Kenichi, Kiminori Sugino, Katsuhiko Masudo, et al.. (2013). Thyroid Lobectomy for Papillary Thyroid Cancer: Long‐term Follow‐up Study of 1,088 Cases. World Journal of Surgery. 38(1). 68–79. 231 indexed citations

20.

Sugino, Kiminori, Kaori Kameyama, Koichi Ito, et al.. (2012). Outcomes and Prognostic Factors of 251 Patients with Minimally Invasive Follicular Thyroid Carcinoma. Thyroid. 22(8). 798–804. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact